5-O-Caffeoylshikimic acid ( —— )

产品货号. M24740 CAS No. 73263-62-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

5-O-Caffeoylshikimic acid
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

5-O-咖啡酰莽草酸具有抗氧化活性；它还具有抗炎活性，其潜在机制与核因子-κB 的下调有关。
产品描述

5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
体外实验

5-O-cafeoylshikimic acid likely to be a key player to modulate NSCLC drug resistance in the near future.
体内实验

——
同义词

——
通路

Apoptosis
靶点

IL Receptor
受体

IL Receptor|NO Synthase|TNF-α
研究领域

——
适应症

——

1.Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators.In Vivo. 2009 Jul-Aug;23(4):545-50.

计算器

产品手册

关联产品

Ixekizumab

Ixekizumab 是一种人源化 IgG4 单克隆抗体，可选择性结合和中和白细胞介素 IL-17A (KD<3 pM)。Ixekizumab 直接阻断IL-17A与IL-17RA的结合，但不与其他IL-17家族成员结合。Ixekizumab 用于中重度斑块型银屑病的研究。
Platycodin D2

Platycodin D2 是一种溶血性较低的皂苷，可改善小鼠对乙型肝炎表面抗原的特异性细胞和体液反应，可安全地用作引发 Th1 和 Th2 免疫反应的佐剂。
Sarilumab

Sarilumab （SAR-153191）is a potent interleukin-6 IL-6 receptor antagonist and a human immunoglobulin G1 monoclonal antibody. Sarilumab inhibits IL-6-mediated signaling and reduces inflammation.Sarilumab is used for the prevention and treatment of rheumatoid arthritis.